STRS Ohio’s IGM Biosciences IGMS Stock Holding History

STRS Ohio’s Portfolio IGMS Stock Details IGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,200	Closed	-$93K	–	2041
2022 Q2	$93K	Buy	+5,200	New	+$92.7K	﹤0.01%	1775
2021 Q4	–	Sell	-4,000	Closed	-$263K	–	2251
2021 Q3	$263K	Hold	4,000	–	–	﹤0.01%	1699
2021 Q2	$332K	Sell	4,000 -1,100	-22%	-$81.5K	﹤0.01%	1689
2021 Q1	$391K	Hold	5,100	–	–	﹤0.01%	1650
2020 Q4	$450K	Hold	5,100	–	–	﹤0.01%	1523
2020 Q3	$376K	Buy	5,100 +3,800	+292%	+$225K	﹤0.01%	1478
2020 Q2	$94K	Hold	1,300	–	–	﹤0.01%	1803
2020 Q1	$72K	Hold	1,300	–	–	﹤0.01%	1732
2019 Q4	$49K	Buy	+1,300	New	+$32.7K	﹤0.01%	1899

Other funds holding IGMS

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

STRS Ohio's IGMS Position: Q3 2022 in Review

STRS Ohio sold out of IGM Biosciences (IGMS) in Q3 2022, closing a stake of 5,200 shares — an estimated $93K sold.

STRS Ohio first reported a position in IGMS in Q4 2019 and held it in 9 quarters. The position peaked at $450K in Q4 2020. 92 funds tracked by Wall St. Rank hold IGMS as of Q3 2022.

STRS Ohio reported no remaining IGM Biosciences position as of Q3 2022 after selling out during the quarter.
STRS Ohio sold 5,200 IGM Biosciences shares in Q3 2022, an estimated $93K.
STRS Ohio first reported a position in IGM Biosciences in Q4 2019 and held it in 9 quarters.
STRS Ohio's IGM Biosciences position peaked at $450K in Q4 2020.
92 funds tracked by Wall St. Rank held IGM Biosciences as of Q3 2022.

Based on STRS Ohio's 13F filing for Q3 2022, filed 27 Oct 2022.